175 related articles for article (PubMed ID: 9426515)
1. Acute myeloid leukemia with minimal differentiation. A multiple parameter study.
Cohen PL; Hoyer JD; Kurtin PJ; Dewald GW; Hanson CA
Am J Clin Pathol; 1998 Jan; 109(1):32-8. PubMed ID: 9426515
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
4. Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemia.
Kondo H; Kobayashi A; Iwasaki H
Cancer Genet Cytogenet; 2001 May; 127(1):77-9. PubMed ID: 11408071
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
[TBL] [Abstract][Full Text] [Related]
6. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
[TBL] [Abstract][Full Text] [Related]
7. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
8. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases.
Sempere A; Jarque I; Guinot M; Palau J; García R; Sanz GF; Gomis F; Pérez-Sirvent ML; Senent L; Sanz MA
Leuk Lymphoma; 1993 Dec; 12(1-2):103-8. PubMed ID: 8161925
[TBL] [Abstract][Full Text] [Related]
10. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
[TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
14. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics.
Villamor N; Zarco MA; Rozman M; Ribera JM; Feliu E; Montserrat E
Leukemia; 1998 Jul; 12(7):1071-5. PubMed ID: 9665192
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
19. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]